← ANALYST RATINGS · TIPRANKS

Intuitive Surgical (ISRG): analyst forecast and price target

$427 −0.27% close 16.10.26 · market cap $151B · Healthcare · Medical - Instruments & Supplies QQQ 0.64%SPY 0.22%
Price targets and ratings of

Analyst consensus

Strong Buy

15 Buy2 Hold0 Sell

Ratings of 17 analysts in the last 3 months

12-month forecast

$489+14.7% upside

Based on 17 price targets given in the last 3 months, the average target is $489, the highest $685, the lowest $391. The average is +14.7% from the last price of $427.

$400$500$600$700Jan 26AprJulOctJan 27AprJulOctHigh$685Average$489Low$391
Highest target $685 Average target $489 Lowest target $391
AnalystFirmPrice target RatingUpsideAction Date Move vs SPY
Anthony Petrone★★★★★★★★★★#1225 · hits 54% · avg +8.5% Mizuho Securities $400 → $415+3.8% Hold −2.7% Assigned 13.10.26on TipRanks 07:35 −1.3%next day +0.6%
Patrick Wood★★★★★★★★★★#10768 · hits 50% · avg −2.1% UBS $500 Buy +17.2% Reiterated 13.10.26on TipRanks 06:26 −1.3%next day +0.6%
Ryan Zimmerman★★★★★★★★★★#3375 · hits 46% · avg +3.3% BTIG $469 → $454−3.2% Buy +6.4% Reiterated 12.10.26on TipRanks 08:40 +0.9%next day −1.3%
Mike Kratky★★★★★★★★★★#1691 · hits 46% · avg +12.9% Leerink Partners $454 → $473+4.2% Buy +10.9% Assigned 12.10.26on TipRanks 07:35 +0.9%next day −1.3%
Adam Maeder★★★★★★★★★★#1026 · hits 54% · avg +11.3% Piper Sandler $470 Buy +10.1% Reiterated 07.10.26on TipRanks 07:26 +2.7%next day +0.6% · 5 days +2.4%
Matt Miksic★★★★★★★★★★#2645 · hits 55% · avg +3.9% Barclays $485 Buy +13.7% Initiated 07.10.26on TipRanks 03:55 +2.7%next day +0.6% · 5 days +2.4%
Joanne Wuensch★★★★★★★★★★#3684 · hits 55% · avg +2.3% Citi $500 Buy +17.2% Reiterated 05.10.26on TipRanks 07:21 +3.0%next day −1.0% · 5 days +4.8%
Name not given — $575 Buy +34.8% Reiterated 01.10.26on TipRanks Oct 2 21:45 −1.5%next day −3.1% · 5 days +2.2%
Travis Steed★★★★★★★★★★#3596 · hits 53% · avg +3.0% Bank of America Securities $470 Buy +10.1% Reiterated 21.09.26on TipRanks 06:10 +0.6%next day +0.1% · 5 days +4.3%
Ryan Zimmerman★★★★★★★★★★#3375 · hits 46% · avg +3.3% BTIG $469 Buy +9.9% Reiterated 07.09.26on TipRanks 22:05 −4.0%next day +1.3% · 5 days +8.8%
Vik Chopra★★★★★★★★★★#6076 · hits 45% · avg +1.9% BMO Capital — Buy — Reiterated 28.08.26on TipRanks Aug 30 13:56 +1.7%next day +1.4% · 5 days −1.7%
Adam Maeder★★★★★★★★★★#1026 · hits 54% · avg +11.3% Piper Sandler $470 Buy +10.1% Reiterated 21.08.26on TipRanks 06:45 +0.7%next day −1.1% · 5 days −2.1%
Joanne Wuensch★★★★★★★★★★#3684 · hits 55% · avg +2.3% Citi $500 Buy +17.2% Reiterated 13.08.26on TipRanks 06:55 −0.7%next day −1.5% · 5 days −4.7%
Suraj Kalia★★★★★★★★★★#1646 · hits 50% · avg +6.8% Oppenheimer $500 Buy +17.2% Upgrade 12.08.26on TipRanks 06:30 −0.2%next day −0.7% · 5 days −0.4%
Lee Hambright★★★★★★★★★★#10167 · hits 49% · avg −1.6% Bernstein $685 Buy +60.5% Reiterated 11.08.26on TipRanks Aug 12 09:45 +2.3%next day −0.2% · 5 days −2.1%
Mathew Blackman★★★★★★★★★★#2177 · hits 49% · avg +9.2% TD Cowen $485 Buy +13.7% Reiterated 03.08.26on TipRanks Aug 4 01:20 +4.8%next day −3.7% · 5 days +2.8%
Helen Fang★★★★★★★★★★#4974 · hits 50% · avg +6.9% HSBC $391 Hold −8.4% Downgrade 30.07.26on TipRanks 07:50 −1.7%next day −0.6% · 5 days +2.3%
Patrick Wood★★★★★★★★★★#10768 · hits 50% · avg −2.1% UBS $550 → $500−9.1% Buy +17.2% Upgrade 28.07.26on TipRanks 08:22 +1.2%next day −0.9% · 5 days −2.3%
Larry Biegelsen★★★★★★★★★★#2729 · hits 53% · avg +3.8% Wells Fargo $487 Buy +14.1% Reiterated 23.07.26on TipRanks Jul 24 05:10 −1.3%next day +1.5% · 5 days +5.8%
Robbie Marcus★★★★★★★★★★#1974 · hits 51% · avg +6.5% J.P. Morgan $450 Buy +5.5% Reiterated 21.07.26on TipRanks Jul 24 05:10 −1.7%next day −2.6% · 5 days +4.3%
Unknown Analyst Mirae Asset — Buy — Upgrade 21.07.26on TipRanks Jul 24 05:10 −1.7%next day −2.6% · 5 days +4.3%
Jayson Bedford★★★★★★★★★★#819 · hits 60% · avg +8.6% Raymond James $577 → $483−16.3% Buy +13.2% Reiterated 17.07.26on TipRanks 08:55 −13.2%next day +2.4% · 5 days −1.7%
Brandon Vazquez★★★★★★★★★★#11688 · hits 42% · avg −5.1% William Blair — Buy — Reiterated 17.07.26on TipRanks 07:06 −13.2%next day +2.4% · 5 days −1.7%
David Rescott★★★★★★★★★★#3448 · hits 49% · avg +5.1% Robert W. Baird $525 → $500−4.8% Buy +17.2% Reiterated 17.07.26on TipRanks 06:46 −13.2%next day +2.4% · 5 days −1.7%
Mike Kratky★★★★★★★★★★#1691 · hits 46% · avg +12.9% Leerink Partners $573 → $454−20.8% Buy +6.4% Reiterated 17.07.26on TipRanks 06:19 −13.2%next day +2.4% · 5 days −1.7%
Richard Newitter★★★★★★★★★★#1772 · hits 48% · avg +6.6% Truist Financial $510 Buy +19.5% Reiterated 17.07.26on TipRanks Jul 16 10:15 +4.0%next day −13.2% · 5 days −15.8%
Rick Wise★★★★★★★★★★#7800 · hits 51% · avg +0.1% Stifel Nicolaus $670 → $550−17.9% Buy +28.9% Assigned 17.07.26on TipRanks Jul 14 09:35 −7.1%next day +2.1% · 5 days −7.3%
Shagun Singh Chadha★★★★★★★★★★#9557 · hits 48% · avg −0.4% RBC Capital $600 → $575−4.2% Buy +34.8% Reiterated 16.07.26on TipRanks Jul 17 07:06 +4.0%next day −13.2% · 5 days −15.8%
Anthony Petrone★★★★★★★★★★#1225 · hits 54% · avg +8.5% Mizuho Securities $525 → $400−23.8% Hold −6.3% Reiterated 15.07.26on TipRanks 07:50 +2.1%next day +4.0% · 5 days −11.4%
Vijay Kumar★★★★★★★★★★#2375 · hits 54% · avg +4.8% Evercore ISI $480 → $430−10.4% Hold +0.8% Reiterated 06.07.26on TipRanks 08:50 +0.7%next day −0.8% · 5 days −5.7%
David Roman★★★★★★★★★★#3715 · hits 53% · avg +5.3% Goldman Sachs $558 Buy +30.8% Reiterated 15.06.26on TipRanks 06:45 −0.4%next day +0.7% · 5 days −0.6%
Imron Zafar★★★★★★★★★★#3477 · hits 85% · avg +20.1% Deutsche Bank $440 → $366−16.8% Sell −14.2% Reiterated 02.06.26on TipRanks 09:35 −2.6%next day +1.9% · 5 days +9.0%
Unknown Analyst Erste Group — Hold — Reiterated 05.05.26on TipRanks May 12 21:02 −1.0%next day −1.3% · 5 days −6.3%
Matt Miksic★★★★★★★★★★#2645 · hits 55% · avg +3.9% Barclays $712 → $651−8.6% Buy +52.6% Assigned 23.04.26on TipRanks 06:25 −0.6%next day −0.1% · 5 days −5.9%
Unknown Analyst Jefferies $515 Hold +20.7% Reiterated 22.04.26on TipRanks 09:55 +6.2%next day −0.6% · 5 days −6.2%
Nico Chen★★★★★★★★★★#2913 · hits 59% · avg +9.8% DBS $480 Hold +12.5% Reiterated 18.03.26on TipRanks Mar 19 07:55 +0.4%next day +0.7% · 5 days −1.2%

Every rating the collector has kept for the last 12 months, including the earlier ones of the same analyst. Latest of each analyst

Best analysts covering Intuitive Surgical

TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.

Most accurate

3 months Mike Kratky★★★★★★★★★★Leerink Partners · #1691
Hits 46%71 of 155 Average return +12.9%
1 year Joanne Wuensch★★★★★★★★★★Citi · #3684
Hits 55%271 of 496 Average return +2.3%
2 years Joanne Wuensch★★★★★★★★★★Citi · #3684
Hits 55%271 of 496 Average return +2.3%

Most profitable

3 months Mike Kratky★★★★★★★★★★Leerink Partners · #1691
Hits 46%71 of 155 Average return +12.9%
1 year Robbie Marcus★★★★★★★★★★J.P. Morgan · #1974
Hits 51%185 of 362 Average return +6.5%
2 years Robbie Marcus★★★★★★★★★★J.P. Morgan · #1974
Hits 51%185 of 362 Average return +6.5%

How the average price target moved

The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 01.10.26: target $490 at a price of $407 (+20.5%); now: $489 at $427 (+14.7%).

$350$400$450$500Sep 15Oct 1Oct 15Top analysts$471Average target$489Price$427

PriceAverage targetTop analysts’ target

Recommendation trend

0204023151Oct 252306Nov307Dec297Jan 26327Feb298Mar267Apr2257May22651Jun43641Jul33831Aug3373Sep1171Oct

Strong BuyBuyHoldSell

Rating05.2606.2607.2608.2609.2610.26
Strong Buy224331
Buy252636383717
Hold754331
Sell011100

Earnings and sales forecast

Next report: 20.10.26 (Q3 2026, date not confirmed)

Earnings per share

Next quarter’s EPS estimate — $2.65 (from $2.53 to $2.76). Last quarter: $2.80.

Sales

Next quarter’s sales estimate — $2.9B (from $2.8B to $3.0B). Last quarter: $2.9B.

Best top-analyst consensus in the sector · Healthcare

AXGNAxoGen
MDWDMediwound
OCULOcular Therapeutix
OVIDOvid Therapeutics
ZYMEZymeworks
About Intuitive Surgical
  • CEO: David J. Rosa
  • Employees: 17,021
  • 1020 Kifer Road, Sunnyvale, CA, 94086-5304, US
  • www.intuitive.com

Intuitive Surgical, Inc. is a leading medical technology firm dedicated to advancing patient care by developing, producing, and commercializing sophisticated tools. These innovations empower medical professionals to deliver superior, accessible, and less-invasive treatment options to patients both within the United States and across international markets. Its flagship offering, the da Vinci Surgical System, facilitates intricate operations through a minimally disruptive approach. Expanding beyond surgical applications, the company also provides the Ion endoluminal system, designed for diagnostic interventions like minimally invasive lung biopsies. Complementing its primary systems, Intuitive Surgical supplies a comprehensive array of instruments, including stapling tools, energy devices, and essential core components. Furthermore, it offers structured training programs to ensure proficient use of its technology, alongside extensive customer support services encompassing installation, repairs, and ongoing maintenance. The firm also integrates digital capabilities to deliver unified, connected solutions that optimize hospital performance through actionable insights. Established in 1995, Intuitive Surgical maintains its corporate headquarters in Sunnyvale, California.

Data from the stock’s TipRanks forecast page, read 43 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗